17Jan

Todd Gabianelli, Partner at Green Key leading the Pharma team, was recently selected as an Old Master at Purdue University. Established in 1950, the Purdue Old Masters Program is an annual event that invites accomplished individuals to share their insights and experiences with students. Over 600 distinguished figures have contributed to this tradition over the years, representing diverse fields. 

According to Purdue Old Masters, “To Purdue students and faculty, an Old Master is an exceptional person who has made significant contributions to his or her own field. There is no typical Old Master, all walks of life are represented. It is not necessary for an Old Master to be a graduate of Purdue. Each person, however, possesses the same desire to share philosophies and experiences with Purdue students.” 

Todd was invited back to Purdue’s campus, where he had the opportunity to speak with several classes on how the decisions he made during his college experience set him up for a career in sales and recruiting.     

To be chosen as an Old Master, alumni first need to be nominated, and then selected by the Central Committee, comprising of student leaders and advisors who organize the program every year. The program offers Purdue students the opportunity to interact with the Old Masters in various classroom settings, round-table discussions, and topic driven panels throughout the multi-day program. 

We had the opportunity to chat with Todd about his experience as an Old Master and how his time at Purdue set him up for a successful career in recruiting!

What does this honor mean to you? 

“It was an incredible honor to be selected as a Purdue Old Master, a top 5 life moment!  The students that planned, hosted, and executed the Old Masters program laid it out in such a way that gave us the opportunity to have meaningful interactions with the students, student leaders, faculty, and former mentors. The Old Masters experience is a 73-year-old annual event designed to give Purdue students the opportunity to learn from alumni and various others that have built successful careers and/or business and have made an impact on others along the way.  It was fun to be back on campus and tell the story about how I ended up at Purdue sight unseen from a small town in Connecticut and to share the many obstacles I had to overcome, mostly academic, while at school that helped prepare me for my career.” 

Can you share some of the experiences or lessons from your career that you imparted to Purdue students as an old master? 

“One of the lessons I shared was to always be looking a few years ahead of where you want to be in your career, find people doing what you want to be doing at a high level and get around them.  The old saying that ‘success leaves clues’ is true and those that have found success are often the ones willing to share the most to help others be successful.” 

In your journey, what aspects of your Purdue education have played a significant role in shaping your success? 

“Although my professors were great, I attribute a lot of my growth and success at Purdue to the experiences I had outside of the classroom in various student organizations.  I was on an Education/Guidance counseling track so not exactly a direct path to a career in sales, but the skills that I learned and developed studying this curriculum ultimately gave me a competitive advantage that helped propel the growth of my career.” 

What advice do you have for current students who aspire to follow in your footsteps? 

“One of my favorite quotes is simple and straightforward; ‘Successful people are those willing to do the things that others aren’t.’ I’ve used this as a guide for the decisions I’ve made along the way in my career and my advice would be the same to the students regardless of which major they are in, or career path they are pursuing.  Create good daily habits, get out of your comfort zone each day, and find ways to help other people get what they want.” 

Jun 6, 2023

What’s the Difference Between the COVID Vaccines?

With the approval last month of the Moderna vaccine by the Food and Drug Administration, we now have two COVID-19 vaccines available. Two more – one from Johnson & Johnson the other from AstraZeneca – are on the way and could be approved as soon as February.

Healthcare workers, residents of nursing facilities and some first responders have already received the Pfizer vaccine, the first one approved by the FDA. Moderna has begun shipping its vaccine with the first of the 25 million initial doses administered last month.

People eager to be immunized have inundated doctors’ offices and clinics asking when the vaccine will be available. The best answer is soon.

Which one, though, will you receive? And does it make any difference?

The answer to the first question is whichever vaccine can be obtained the quickest or, in some cases, whichever your health plan recommends. It really doesn’t make any difference to you.

Both vaccines require two separate doses to reach maximum effectiveness 21 days apart for Pfizer and 28 days for the Moderna version. Both protect about equally well. The FDA data shows Pfizer is 95% effective after both doses. Moderna is 94.1%.

Unlike most other vaccines, these two vaccines use pieces of protein from the SARS-CoV-2 virus to prompt the body to create antibodies. Conventional vaccines, like the annual flu shot, are manufactured from viruses typically grown in chicken eggs. These chicken grown viruses are then killed or weakened to become vaccines.

The COVID vaccines employ messenger RNA (mRNA), a newer technology. These vaccines “teach” the body to replicate the little bit of the CoV-2 protein, which, in turn, creates an immune response causing the body to make the antibodies that provide the protection against the virus.

The most significant difference between the Moderna and the Pfizer vaccines is how they must be stored. Both can survive for a few days in standard refrigeration. For longer periods, the less stable Pfizer vaccine must be kept in ultra-low temperatures below -94 F. That makes shipping and storing Pfizer’s vaccine somewhat more complicated, especially outside urban areas where the low temperature refrigeration is not easily available.

“At the end of the day, these two vaccines are pretty similar,” Dr. Thomas Russo, professor and chief of infectious disease at the State University of New York, tells Health. “Grab it while you can.”

Photo by Hakan Nural

[bdp_post_carousel]